This report studies the global Tuberculosis Drugs market, analyzes and researches the Tuberculosis Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
The global tuberculosis drugs market was valued at around USD 895.5 million in 2017 and is anticipated to exhibit a CAGR of 6.3% during the forecast period.
Tuberculosis (TB) infection treatment comprises of 4 drug regimen isoniazid, rifampin, pyrazinamide, and either ethambutol or streptomycin to sterile or kill the Mycobacterium ... Read more
